Octreotide

Octreotide Full Name

Octreotide

Alternate Names for Octreotide

Octreotide; Sandostatin; Octreotide Acetate Salt; Octreotide-LAR; Octreotide acetate; Sandoz 201-995; C49H66N10O10S2; 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide; Compound 201 995; Compound 201-995; Compound 201995; SAN 201 995; SAN 201-995; SAN 201995; Sandoz 201 995; Sandoz 201-995; Sandoz 201995; SM 201 995; SM 201-995; SM 201995; SMS 201 995; SMS 201-995; SMS 201995; Octreotide; Sandostatine; Octreotide Acetate Salt; Octreotide-LAR; Octreotide acetate; Octreotidum [Latin]; Octreotida [Spanish]; AC1L8LCD; Octreotide (USAN/INN); Longastatin; Octreotide [USAN:INN:BAN]; C07306; 83150-76-9; C5H12O2.C4H10; NCI60_025753; LS-177735; D00442; L000453; Octreotida; Octreotidum; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2-7)-disulfide, (R-(R*,R*))-; 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide; AC1L1GVU; AC1L9M4X